|
|
SECOND NATIONAL COMPARATIVE EFFECTIVENESS SUMMIT
September 13 - 14, 2010
ONSITE
Crystal Gateway Marriott
Arlington, VA
ONLINE
In your own office or home live via the Internet with 24/7 access for six months
|
COMPARATIVE EFFECTIVENESS SUMMIT ONLINE ARCHIVE LOG IN
|
|
Click here to log into Comparative Effectiveness video archive.
|
|
|
FEATURING SPECIAL SESSIONS ON
|
|
Role of the Patient Centered Outcomes Research Institute (PCORI)
Comparative Effectiveness Research: The Legislative History and Future
Overview of Federal Stimulus Funding of CER
How States are Already Using Comparative and Cost-effective Research
Methods and Data Infrastructure Needed for CER
The Role of HIT in Comparative Effectiveness Research
Comparative Effectiveness versus Cost-Effectiveness
The Relationship between AHRQ and CMS through the Lens of CER
Comparative Effectiveness Research and the FDA
Balancing Comparative Effectiveness Research and Personalized Medicine
Initiatives under way to Develop Evidence of CER and put it into Practice
The Impact of CER on Health and Health Care Spending
|
|
AND TRACKS ON
|
|
CER for Public Programs
CER for Employers and Health Plans
CER for Pharma and Device Manufacturers
CER for Healthcare Providers
|
FREE SUBSCRIPTION TO MONTHLY
COMPARATIVE EFFECTIVENESS e-NEWSLETTER
|
Click here to subscribe to a monthly Accountable Care Update e-Newsletter, one of a family of free e-Newsletters providing a complimentary video presentation and regularly updated news and key resources on major health care issues. To view and subscribe to other e-Newsletters on patient safety, ACOs, Medicaid, and readmissions, go to www.HealthCareeNewsletters.com.
|
|
|
GRANTORS
|
|
|
ADDITIONAL GRANTOR
|
|
|
SECOND NATIONAL COMPARATIVE EFFECTIVENESS SUMMIT
September 13 - 14, 2010
|
ONSITE
Crystal Gateway Marriott
Arlington, VA
|
OR |
ONLINE
In your own office or home live via the Internet
with 24/7 access for six months
|
 |
|
|
|
KEYNOTE SPEAKERS
|
Carolyn M. Clancy, MD
Director, Agency for Healthcare Research and Quality (AHRQ), Department of Health and Human Services, Washington, DC |
Francis S. Collins, MD, PhD
Director, National Institutes of Health, Former Director, National Human Genome Research Institute, Author, The Language of Life: DNA and the Revolution in Personalized Medicine (2010), Bethesda, MD
|
Kavita Patel, MD, MSHS
Director, Health Policy Program, New America Foundation, Former Senior Adviser to Valerie Jarrett, the White House, Former Deputy Staff Director, Senate Health Subcommittee, Washington, DC |
Gail Wilensky, PhD
Senior Fellow, Project HOPE, Former Administrator, Health Care Financing Administration, Washington, DC
|
|
|
|
|
SUMMIT CHAIR
|
John Iglehart
Founding Editor, Health Affairs, National Correspondent, New England Journal of Medicine, Washington, DC
|
|
|
|
|
LEGISLATIVE HISTORY AND FUTURE
|
Stephen Cha, MD, MHS
Professional Staff, Committee on Energy and Commerce, United States House of Representatives, Washington, DC |
Keith Flanagan, Esq.
Health Counsel to Ranking Member Enzi, Health Committee, United States Senate, Washington, DC |
Sarah Kuehl (Invited)
Professional Staff (Conrad), Budget Committee, United States Senate, Washington, DC
|
|
|
|
|
COVERAGE AND PAYMENT POLICY
|
Elise Berliner, PhD
Director, Technology Assessment Program, Agency for Healthcare Research & Quality, Washington, DC |
Louis B. Jacques, MD
Director, Coverage & Analysis Group, Office of Clinical Standards and Quality, Centers for Medicare & Medicaid Services, Washington, DC |
Tamara Syrek Jensen, J.D.
Deputy Director, Coverage and Analysis Group, Office of Clinical Standards and Quality, Centers for Medicare & Medicaid Services, Washington, DC
|
Susan G. Merewitz, Esq.
Former Senior Attorney, Agency for Healthcare Research and Quality, Office of General Counsel, Public Health Division, Department of Health and Human Services, Rockville, MD |
Jason B. Caron, Esq.
Associate, EpsteinBeckerGreen, Washington, DC (Moderator)
|
|
|
|
|
CER FOR PUBLIC PROGRAMS
|
Elizabeth Docteur
Vice President and Director of Policy Analysis, Center for Studying Health System Change, Washington, DC |
Joel Kupersmith, MD
Chief Research and Development Officer, Veterans Administration, Washington, DC |
Judy Zerzan, MD, MPH
Colorado Medicaid Medical Director, Colorado Department of Health Care Policy, Denver, CO
|
|
|
|
|
CER FOR EMPLOYERS AND HEALTH PLANS
|
Naomi Aronson, PhD
Executive Director, Technology Evaluation Center, Blue Cross Blue Shield Association, Chicago, IL |
David V. Axene, FSA, FCA, MAAA
Founder and President, Axene Health Partners, LLC, Winchester, CA |
|
|
|
|
CER FOR HEALTHCARE PROVIDERS
|
Robert M. Centor, MD, FACP
Associate Dean, Huntsville Regional Medical Campus, University of Alabama at Birmingham, Huntsville, AL |
Ruth Shaber, MD
Medical Director, Kaiser Permanente Care Management Institute, Oakland, CA
|
|
|
|
|
CER FOR PHARMA AND DEVICE MANUFACTURERS
|
Teresa Lee, JD, MPH
Senior Vice President, Advanced Medical Technology Association, Washington, DC |
Newell McElwee, PharmD, MSPH
Executive Director, U.S. Outcomes Research, Merck & Co., Former Vice-President of Outcomes Research, Pfizer, Washington, DC |
Robert Temple, MD
Associate Director for Medical Policy, Center for Drug Evaluation and Research, Food and Drug Administration, Washington, DC
|
|
|
|
|
AND THE FOLLOWING NATIONAL EXPERTS
|
Jerry Avorn, MD
Professor of Medicine, Harvard Medical School, Chief, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Author, "Debate About Funding Comparative Effectiveness Research," New England Journal of Medicine, Boston, MA |
Mark Gibson
Director, Center for Evidence-Based Policy, Oregon Health and Science University, Program Officer, Milbank Memorial Fund, Former Chief of Staff, Oregon Senate President John Kitzhaber, Portland, OR |
Scott Gottlieb, MD
Medical Internist, Stamford Hospital, Former Deputy Commissioner for Medical and Scientific Affairs, FDA, Former Senior Adviser to the Administrator, CMS, Washington, DC
|
David R. Hunt, MD, FACS
Chief Medical Officer, Office of the National Coordinator, Department of Health and Human Services, Washington, DC |
Amy M. Miller, PhD
Public Policy Director, Personalized Medicine Coalition, Washington, DC |
Tomas J. Philipson, PhD
Daniel Levin Professor of Public Policy Studies, Harris School, Associate Faculty Member, Department of Economics, University of Chicago, Chicago, IL
|
Eugene C. Rich, MD
Senior Fellow and Director, Center for Health Care Effectiveness, Mathematica Policy Research, Washington, DC |
Sean Tunis, MD, MSc
Founder and Director, Center for Medical Technology Policy, Former Director, Office of Clinical Standards and Quality and Chief Medical Officer, Centers for Medicare and Medicaid Services, Baltimore, MD |
Milton Weinstein, PhD
Henry J. Kaiser Professor of Health Policy and Management, Department of Health Policy and Management and Department of Biostatistics, Harvard School of Public Health, Boston, MA
|
|
|
|
|
|
